Research centers on molecular mechanisms and therapy development in brain and systemic cancers and neurodegeneration. Uses patient‑derived 3D cultures, animal models, and high‑throughput screens to identify biomarkers, validate targets, and advance photomedicine‑enabled and small‑molecule interventions, and address CNS delivery barriers.